Cureus · 2025
Substance Use Treatment Services in New York (2021-2023): A State Profile Analysis Based on National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) Data.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arisoyin Abimbola E, Ezeani Esther I, Ekarika Edediong, Odega Amaka S, Ahumaraeze Oscar O, Okobi Okelue E
Аннотация
BACKGROUND: Substance use disorders (SUDs) are a significant public health issue in the U.S., with New York State facing rising treatment demands. The National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) offers valuable data on treatment trends across the state.
OBJECTIVE: This study analyzes trends in substance use treatment services in New York from 2021 to 2023 using N-SUMHSS data, focusing on facility capacity, medication-assisted treatment (MAT) utilization, and treatment effectiveness.
METHODS: Secondary data from the N-SUMHSS (2021-2023) were analyzed, examining facility types, client numbers, and MAT use (methadone, buprenorphine, naltrexone). Descriptive statistics and trend analysis were conducted to assess changes in treatment services.
RESULTS: From 2021 to 2023, the number of facilities remained stable, with slight fluctuations. Private non-profit organizations dominated, comprising 69.7% of facilities in 2022-2023. MAT utilization declined in both opioid treatment programs (OTPs) and non-OTP facilities, with methadone usage remaining prevalent. Clients receiving MAT at OTP facilities decreased from 39,534 (9.3%) in 2021 to 34,186 (7.8%) in 2023, while naltrexone use rose. Outpatient services increased to 547 (72.1%), while residential and hospital inpatient facilities saw slight declines.
CONCLUSION: MAT utilization has improved, but challenges persist in addressing the growing demand for residential and detox services. Expanding outpatient and inpatient services, along with greater access to MAT, is crucial to improving treatment in New York.
OBJECTIVE: This study analyzes trends in substance use treatment services in New York from 2021 to 2023 using N-SUMHSS data, focusing on facility capacity, medication-assisted treatment (MAT) utilization, and treatment effectiveness.
METHODS: Secondary data from the N-SUMHSS (2021-2023) were analyzed, examining facility types, client numbers, and MAT use (methadone, buprenorphine, naltrexone). Descriptive statistics and trend analysis were conducted to assess changes in treatment services.
RESULTS: From 2021 to 2023, the number of facilities remained stable, with slight fluctuations. Private non-profit organizations dominated, comprising 69.7% of facilities in 2022-2023. MAT utilization declined in both opioid treatment programs (OTPs) and non-OTP facilities, with methadone usage remaining prevalent. Clients receiving MAT at OTP facilities decreased from 39,534 (9.3%) in 2021 to 34,186 (7.8%) in 2023, while naltrexone use rose. Outpatient services increased to 547 (72.1%), while residential and hospital inpatient facilities saw slight declines.
CONCLUSION: MAT utilization has improved, but challenges persist in addressing the growing demand for residential and detox services. Expanding outpatient and inpatient services, along with greater access to MAT, is crucial to improving treatment in New York.